Takeda Defends UK Patent Protection For ADHD Drug Elvanse
Takeda has swung back after a German rival asked a London court to call time on its extended patent protections for the ADHD treatment Elvanse, arguing that its U.K. supplementary protection...To view the full article, register now.
Already a subscriber? Click here to view full article